Evolution of Poly(ADP-ribose) Polymerase-1 (PARP-1) Inhibitors. From Concept to Clinic

ADVERTISEMENT RETURN TO ISSUEPerspectiveNEXTEvolution of Poly(ADP-ribose) Polymerase-1 (PARP-1) Inhibitors. From Concept to ClinicDana V. Ferraris*View Author Information Johns Hopkins University Brain Science Institute, 855 N. Wolfe Street, Baltimore, Maryland 21205*Contact information. Phone: (410) 614-1107. Fax: (410) 614-0659. E-mail: [email protected]Cite this: J. Med. Chem. 2010, 53, 12, 4561–4584Publication Date (Web):April 5, 2010Publication History Received6 January 2010Published online5 April 2010Published inissue 24 June 2010https://doi.org/10.1021/jm100012mCopyright © 2010 American Chemical SocietyRIGHTS & PERMISSIONSArticle Views7888Altmetric-Citations275LEARN ABOUT THESE METRICSArticle Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated. Share Add toView InAdd Full Text with ReferenceAdd Description ExportRISCitationCitation and abstractCitation and referencesMore Options Share onFacebookTwitterWechatLinked InReddit Read OnlinePDF (5 MB) Get e-AlertscloseSUBJECTS:Amides,Cancer,Cells,Genetics,Inhibitors Get e-Alerts